David Sallman, MD, Moffitt Cancer Center, Tampa, FL, discusses the use of anti-CD47 antibodies in combination with azacitidine for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
Ещё видео!